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ABSTRACT
Background Family carers play a significant role
in managing pain and associated medicines for
people with advanced cancer. Research indicates
that carers often feel inadequately prepared for
the tasks involved, which may impact on carers’
and patients’ emotional state as well as the
achievement of optimal pain control. However,
little is known about effective methods of
supporting family carers with cancer pain
medicines.
Aims To systematically identify and review
studies of interventions to help carers manage
medicines for pain in advanced cancer. To
identify implications for practice and research.
Method A systematic literature search of
databases (MEDLINE, CINAHL, PsycINFO and
AMED) was carried out to identify studies of pain
medication management interventions that
involved family carers of patients with advanced
cancer, and reported specific outcomes for family
carers. Patient pain outcomes were also sought.
Studies were quality appraised; key aspects of
study design, interventions and outcomes were
compared and a narrative synthesis of findings
developed.
Results 8 studies were included; all had
significant methodological limitations. The
majority reported improvements in family carer
knowledge and/or self-efficacy for managing
pain medicines; no effect on patient pain
outcomes; and no adverse effects. It was not
possible to discern any association between
particular intervention characteristics and family
carer outcomes.
Conclusions Current evidence is limited, but
overall suggests face-to-face educational
interventions supported by written and/or other
resources have potential to improve carers’
knowledge and self-efficacy for pain
management. Further research is needed to
identify how best to help family carers manage
pain medicines for patients with advanced
cancer.
INTRODUCTION
Family carers provide much of the essen-
tial care that enables many people with
advanced cancer to live at home as their
illness progresses.1 2 Fear of pain is one
of the most significant concerns for those
approaching the end of life, and 71% of
patients with advanced cancer experience
pain, often requiring treatment with mul-
tiple analgesics, including opioids.3 4
There is increasing recognition of family
carers’ role in managing patients’ symp-
toms and medications, a crucial but often
challenging aspect of providing palliative
care at home.5 Medication management
requires knowledge and practical skills
and involves carers in selecting, adminis-
tering and evaluating the effectiveness of
medicines,6 7 tasks that become more
exacting when complex drug regimens
are prescribed to control cancer pain.4
Internationally, research has repeatedly
described that family carers experience
problems with medication management
as a consequence of their beliefs about
pain and worries about analgesics, par-
ticularly opioids;8 9 knowledge deficits;10
and insufficient information and support
from health professionals.4 11 Recent UK
studies found that family carers report
receiving little information or education
about end-of-life medications, and per-
ceived managing medicines as a demand-
ing and burdensome responsibility that
can provoke anxiety.5 12 Identifying
family carers’ difficulties helps explain
why analgesic use may be inadequate and
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cancer pain control less than optimal.4 13 Deficiencies
in pain and medications management have also been
linked with unnecessary hospital admission.14
Qualitative research has articulated cancer carers’
concerns and needs in relation to pain manage-
ment,5 11 15 and there is consensus that health profes-
sionals should provide family carers with more
information, training and continuing support for this
aspect of their role.5 11 12 16 However, little is known
about the best methods of supporting carers to
manage pain medicines. Most cancer pain interven-
tions have focused on the patient, and systematic
reviews have confirmed their benefits on pain out-
comes.17–19 Few studies have involved family carers or
reported discrete outcomes for carers.20 Systematic
reviews have considered interventions that address a
variety of cancer and palliative carers’ needs,21–25 but
none has specifically or comprehensively appraised
cancer pain medicines management interventions. We
therefore undertook this systematic review of pub-
lished studies evaluating interventions for family
carers managing pain medication for patients with
advanced cancer. The specific questions addressed
were (1) What are the pain medication management
interventions for family carers of patients with
advanced cancer that have been evaluated? (2) What
were their effects, positive or otherwise, on family
carers and on patients’ pain? (3) Were any particular
intervention characteristics or components (eg, inten-
sity, tailoring, timing, underpinning theoretical frame-
work) associated with improved outcomes?
METHODS
Information sources and search strategy
Searches of MEDLINE, CINAHL, PsycINFO and
AMED were initially carried out in 2013 and updated
on 16 September 2014, with no date restrictions.
The MEDLINE search strategy (see online
supplementary appendix 1.1) combined relevant key-
words, including intervention, pain management, pain
medicine, carer, family carer, caregiver, cancer. The
MEDLINE search strategy was adapted for other data-
bases. The electronic searches were supplemented by
scanning citations in related systematic reviews, and in
the articles selected for full text review. Research team
members identified one potentially eligible article that
was not retrieved electronically by networking with
colleagues working in the field of supportive care.
There is no registered protocol for this review, which
was undertaken to inform the development of a
cancer pain medicines management intervention for
family carers as part of a phase I–II feasibility study.26
Eligibility criteria and study selection
Two investigators (EL and JAH) independently read
the titles and abstracts of all records retrieved and
assessed them against the criteria agreed previously by
the research team, shown in table 1. We were inter-
ested in articles reporting evaluation (quantitative or
qualitative) of a pain medication management inter-
vention that included unpaid family carers of adult
patients with advanced cancer, in which data on carer
outcomes had been gathered from the carers them-
selves. Where there was uncertainty about eligibility,
typically because abstracts provided limited informa-
tion about composition of the patient group or carer
outcomes, the article was included at this stage of the
search. The few disagreements about selection were
resolved by a third investigator (SL). The full text of
potentially eligible publications (n=19) was independ-
ently reviewed by at least two authors (SL, JBH and
JAH). At this stage, close attention was paid to the
patient population to verify inclusion of patients with
advanced cancer, for example, from information pro-
vided about diagnosis or stage (metastases) or treat-
ment (palliative or hospice care), and to results
reporting (to confirm family carer outcomes were
included). Final decisions about inclusion of articles
were made by consensus.
Data extraction and analysis
To enable comparison, standardised formats were
developed for extracting information from the
selected studies. Details of the studies charted were:
author, year of publication, country, study population
(patients and family carers), sample size, attrition rate,
study design, intervention characteristics, fidelity
assessment, control group, outcomes specified with
associated measurement instruments, and results
reported for carers and patients. Where articles did
not report patient outcomes we accessed referenced
articles to obtain patient data from the study.
Interventions were categorised according to format
(mode of delivery and follow-up, eg, face-to-face,
video, and resources provided to carers); duration and
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
▸ Study population includes adults
with advanced cancer receiving
palliative care
▸ A discrete intervention, program
or resources that is not standard/
usual care, which
– Includes a focus on pain
medication (but does not need
to focus exclusively on pain or
medication)
– Involves informal/family carers
▸ Study reports family carer
outcomes based on quantitative
or qualitative data collected from
family carers
▸ Any study design
▸ Children or young people
only (under 18 years)
▸ Pain related to surgery for
cancer or other treatment
with curative intent only
▸ Full text not available in
English language
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intensity (number and length of sessions, total dur-
ation and time period); delivery (provider, recipient
and location); detail of intervention components and
content; and the theoretical basis of the intervention.
Information was extracted by one author ( JAH) and
reviewed by two authors (SL and JBH). Discussion of
the comparative charts (SL, AR, JBH and JAH) identi-
fied key points to include in descriptive overviews of
the studies and interventions. We also interrogated the
charts for any patterns that might help explain the
results obtained by the studies. The narrative synthesis
of our findings presented in this paper was developed
through an iterative process of scrutinising the data,
articulating and testing interpretations, drawing on
relevant literature and revising written drafts.
All the included studies were quantitative evalua-
tions, and none had any substantial qualitative compo-
nents. Not all studies were randomised, therefore we
used the quality assessment checklist developed by
Downs and Black,27 which is applicable to randomised
and non-randomised studies. It has five subscales for
quality of reporting, and factors that could systematic-
ally bias results, and provides an overall quality score.
Following other reviews, the question concerning stat-
istical power calculation was modified to a yes/no
answer.28 The checklist has 27 items, with a maximum
score of 28. We used Samoocha et al’s28 method of
grouping scores into four quality levels: excellent (26–
28), good (20–25), fair (15–19) and poor (≤14). One
author (DE) assessed and scored all the full text arti-
cles, and a second author ( JAH) independently
assessed 50% of them, without blinding to authorship
or journal. Differences in scores (a total of 3 items in 2
studies) were resolved by a third author (SL).
RESULTS
The database search found 139 citations, published
1985 to August 2014, from which 20 duplicate
records were discarded. A further 104 records were
excluded following assessment of abstracts, most
because they were descriptive and did not report a
specific intervention (n=77). The remaining 15 arti-
cles from the database search, along with 4 articles
known to the research team and/or identified by cit-
ation searching, comprised the 19 papers read in full.
Eight papers, each reporting a different study, met the
criteria for inclusion in the review. A flowchart sum-
marising the selection process is shown in figure 1.
Study characteristics
The characteristics of the eight studies are shown in
table 2. The studies were published from 1995 to
2013, five were conducted in the USA, and one each
in Taiwan, UK and Norway. Patients were recruited
from hospital outpatient clinics, hospice care and
home nursing services. All the studies included
patients who reported current cancer-related pain;
patient populations were heterogeneous in terms of
cancer diagnoses. Three studies selected only patients
with advanced cancer, and five also included patients
at various stages of illness. Family carers were nomi-
nated by patients as the person most involved in their
care. Carer demographics and information about the
nature of patient-carer dyads were not consistently
provided. All the studies delivered educational inter-
ventions to patients and family carers together, and
included evaluation of the effect on carers: five in ran-
domised control trials (RCT) and three in single-
group prestudies and poststudies, one of which subse-
quently randomised participants to three different
types of follow-up. Most RCTs compared the inter-
vention to usual care; one used attention placebo
control and written information.
The studies included a total of 582 family carer–
patient dyads at baseline; 329 dyads were allocated to
receive interventions (table 2) and, as far as can be
ascertained from the data provided, 326 carers
received an intervention with the patient present;
none of the studies delivered interventions to carers
only. Sample sizes ranged from 10 to 161 dyads at
baseline assessment, with 8–109 dyads reported as
completing follow-up. However, only three studies
provided attrition data: the proportion of carers com-
pleting follow-up in intervention (I) and control (C)
groups in Keefe et al’s29 study at an average of 1 week
were I 68%, C 76%; in Ward et al’s30 study at
5 weeks I 80%, C 75% and at 9 weeks I 69%, C
67%; and in Capewell et al’s31 study 8 of the 10
carers who received the intervention completed
follow-up to 1 month. Heterogeneity in patient popu-
lations, educational interventions, outcome measures
and timing of data collection makes quantitative
meta-analysis inappropriate.
Study quality
Total quality scores for the studies ranged from 7 to
20 (out of a possible total of 28 on the Downs and
Black27 checklist), with a median of 12. The checklist
also creates a profile of the methodological strengths
and weaknesses of a paper, assessing quality of report-
ing; internal validity (bias and confounding); external
validity and power. Scores on these dimensions for
each study are shown in table 3. Deficiencies in design
and methods were found in most studies. The two
studies with the highest total scores29 30 achieved the
‘good’ category in Samoocha et al’s28 four-level classi-
fication; the other six studies had scores at the ‘poor’
level. None were classified as excellent or fair. Low
total scores reflect inadequate reporting that often
prevented assessment of items relating to risk of bias,
but may, in part, be a consequence of the methodo-
logical challenges inherent in conducting research on
interventions in palliative care.32 Internal validity
scores were reduced because the educational interven-
tions in these studies precluded blinding of recipients
and those delivering the intervention; in addition,
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Figure 1 Systematic selection process.
Table 2 Characteristics of studies included in the review
Lead
author Year Country Description of sample Study design
Number of family carers
at baseline in
Intervention
Control
(UC or APC)
Ferrell 1995 USA Family carers of hospital outpatients aged 60+ years with
cancer-related pain duration ≥3 months; prescribed opioid
analgesia
SGPP 50 –
Wells 2003 USA Family carers of hospital outpatients with cancer pain of
onset or escalation in last 3 months; managed by analgesia;
life expectancy >6 months
SGPP then 3-arm
RCT of follow-up
a. Patient-initiated
b. Nurse-initiated
64
a. 21
b. 19
−24 (UC)
Keefe 2005 USA Family carers of hospice and hospital outpatients with
advanced cancer diagnosis; disease-related pain (worst >3
BPI); life expectancy <6 months
2-arm RCT 41 37 (UC)
Lin 2006 Taiwan Family carers of hospital outpatients with cancer pain taking
oral analgesics
2-arm RCT 31 30 (UC)
Ward 2009 USA Family carers of hospital outpatients with cancer diagnosis,
reporting moderate to severe pain in past 2 weeks;
performance status score indicating out of bed >50% of
waking hours
3-arm RCT
a. Dyad
b. Patient only
a. 51
b. 53
57 (UC)
Capewell 2010 UK Family carers of patients receiving palliative care from
hospital outpatient clinics or community teams; living at
home; pain from active cancer rated ≥3 on 0–10 scale
SGPP 10 –
Vallerand 2010 USA Family carers of patients with cancer pain receiving care from
home care nurses (not hospice nurses)
Cluster RCT 24 22 (UC)
Valeberg 2013 Norway Family carers of hospital outpatients with cancer diagnosis
and radiographic evidence of bone metastasis; pain ≥2.5 on
1–10 scale; KPS ≥50
2-arm RCT 58 54 (APC+
booklet)
Study design: RCT, randomised controlled trial; SGPP, single group pretest and post-test design.
Control: APC, attention placebo control; UC, usual care.
BPI, Brief Pain Inventory.
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blinding of researchers assessing outcomes was often
not achieved or was ambiguously reported. Only one
study had a statistical power calculation; some studies
were of very small scale, or designated by the authors
as ‘preliminary’ or exploratory research. There is no
apparent trend towards better reporting or more
rigorous methodology, with year or decade of
publication.
Intervention characteristics
All eight interventions included between one and
three face-to-face education or training sessions, typic-
ally supported by written and/or other resources,
opportunities for questions and discussion, and
follow-up contacts for reinforcement or further coach-
ing (table 4). The interventions were delivered to
patients and family carers together by a specially
trained clinician (nurse, psychologist) or a researcher
in the patient’s home (5 studies29 30 33–35), or in hos-
pital outpatient clinics (3 studies31 36 37). None of the
studies used health professionals who were providing
routine patient care to deliver interventions, although
Vallerand et al’s34 study included home care nurses,
some of whom received pain management education
(Power over Pain) independently of the patient-carer
dyads they recruited to the trial.
The duration and intensity of interventions, and the
period of time over which they were delivered varied
greatly between studies. Some authors provided insuf-
ficient information to precisely quantify intensity of
intervention, and the boundaries of interventions
were not always clearly defined: for example, specify-
ing whether ‘follow-up’ contacts with participants
were for educational or assessment purposes.
However, we were able to classify interventions as
higher or lower intensity, based on Cummings
et al’s18 definition of intensive education: more than
four education sessions, or a cumulative total duration
of more than 2 h in one setting. None of the interven-
tions in this review involved more than three educa-
tion sessions. Two studies reported interventions with
a total duration of 2 or more hours in the same
setting.29 33 Both these interventions had a model of
three face-to-face education sessions with a total dur-
ation of 2–3 h, delivered over a maximum of 2 weeks,
which is similar to that described by Valeberg et al,35
who did not report the length of sessions. Our inter-
pretation of the information supplied in the other five
articles is that the initial education session plus
follow-up did not exceed a maximum duration of
100 min (mean durations quoted were briefer), thus,
these interventions were categorised as lower
intensity.30 31 34 36 37
All the interventions focused on managing pain and
pain medication, addressing widely recognised ‘bar-
riers’ to pain management: knowledge about how
analgesics work; beliefs about addiction and toler-
ance; fears about side effects and overdose; excessive
stoicism; and poor communication between patients,
family carers and health professionals.9 They included
cognitive and behavioural components, providing a
mixture of information and teaching or coaching to
develop practical and coping skills, solve problems
and/or improve communication. Some interventions
had additional components, such as providing infor-
mation or training in non-drug pain management, for
example, relaxation, massage and imagery;29 33 creat-
ing plans to maintain coping;29 change behaviour or
anticipate problems, which could be reviewed and
revised during follow-up.30 35 Structured and tailored
elements were present in all interventions, but they
differed in the emphasis placed on eliciting and
responding to the particular needs and circumstances
of a patient–carer dyad. Those with minimal tailoring
delivered standardised content and required partici-
pants to raise questions or concerns.31 37 A higher
degree of tailoring was achieved by initially identify-
ing participants’ gaps in knowledge, misconceptions,
concerns or needs (eg, by structured interaction29 30
or questionnaire35), and the information was then
used to provide individualised education. Some inter-
ventions also assessed learning and/or provided
further coaching to modify pain management
plans.30 35
Only one study referenced a theoretical framework
underpinning the intervention. Ward et al’s30
Table 3 Study quality: reporting and risk of bias summary (Downs and Black27)
Study lead
author, date
Reporting
score n/11
External
validity score
n/3
Internal validity
—bias score n/7
Internal validity—
confounding score n/6
Power
score n/1
Total score
n/28
Quality
level*
Ferrell, 1995 4 1 2 0 0 7 Poor
Wells, 2003 6 1 4 2 0 13 Poor
Keefe, 2005 9 3 3 5 0 20 Good
Lin, 2006 6 1 3 2 0 12 Poor
Ward, 2009 8 2 5 4 1 20 Good
Capewell, 2010 6 1 2 1 0 10 Poor
Vallerand, 2010 5 1 3 2 0 11 Poor
Valeberg, 2013 6 1 3 2 0 12 Poor
*Based on Samoocha et al’s28 classification of quality level: excellent (26–28); good (20–25); fair (15–19); poor (≤14).
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Table 4 Pain medication management interventions for family carers of patients with advanced cancer
First author,
year, country
Intervention: format*, resources
provided to carers, follow-up Duration and intensity of intervention† Provider, recipients, site of delivery.
Detail of intervention content
theoretical basis
Ferrell, 1995,
USA
3 Face-to-face interactive teaching
sessions
Printed instructions for drug and
non-drug treatment
Audiotapes of first 2 sessions
US$50 for non-drug equipment
Follow-up: 2 additional visits (only data
collection?)
3 1 h sessions delivered over 2 weeks. Total
duration 3 h
Follow-up visits at 1 and 3 weeks after
intervention: duration NR
Teaching sessions delivered by experienced
specialist nurse in the patient’s home to patient
alone or patient and carer together
Pain education program with cognitive/behavioural
components
1. General information about pain, pain assessment
and importance of pain relief
2. Drug treatment and medication management
3. Non-drug treatment of pain, including
demonstrations, promotion of combining drug
and non-drug approaches
Caregivers were instructed on how to support the
patient
Theoretical basis: NR
Wells, 2003,
USA
Single interactive education session:
15 min video followed by face-to-face
discussion of content and patient’s
current medication
Printed information on analgesics
Follow-up: (1) patient given phone
number for pain ‘hotline’ (no cost); (2)
provider-initiated telephone calls; (3)
usual care
Single session duration 20–30 min. Follow-up:
no calls were made to the ‘hotline’.
Provider-initiated weekly phone calls for
4 weeks, lasting 5–15 min. Total duration 20–
60 min
Education session in hospital outpatient clinic; NR
who delivered to patient and carer together. Video
featured expert clinicians and patients. Follow-up
phone calls: specialist oncology nurse, NR
recipient (patient or carer)
Cognitive intervention. Video included information
about pain, methods to control pain, opioids, low risk
of addiction, side effects of pain meds, and emphasised
the importance of communicating pain to providers
Follow-up telephone calls: nurse-assessed patients’
understanding of pain medicines, asked about any
problems
Theoretical basis: NR
Keefe, 2005,
USA
3 face-to-face interactive education/
training sessions eliciting concerns and
providing coaching to develop coping
strategies
Printed materials (book)
Video and audio tapes
3×45–60 min sessions (average 56 min)
delivered over 1–2 weeks (average 14 days,
range 8–32 days)
Total duration 2.25–3 h
Education/training sessions delivered by nurse
educator in the patient’s home to patient and
carer together
Partner-guided pain management training provided
1. Information on managing cancer pain,
addressing specific concerns raised by
participants
2. Training in cognitive and behavioural pain-coping
skills (relaxation and imagery, activity-rest cycle)
using behavioural rehearsal procedure, including
guiding partner to coach patient to acquire and
maintain coping skills
3. Feedback on use of methods and skills taught
4. Help to devise a coping maintenance plan
Theoretical basis: NR
Lin, 2006,
Taiwan
Face-to-face session at which content of
booklet presented. Questions elicited
and answered. Participants encouraged
to phone if questions arose
Copy of booklet
Follow-up: 2 face-to-face sessions,
information reiterated and questions
answered
Initial session 30–40 min.Follow-up at 2 and
4 weeks after initial session: duration NR
Intervention delivered by a researcher to patient
and carer together in a private room in the
hospital outpatient clinic
Cognitive intervention. Culturally specific booklet
developed from earlier research into patient barriers to
cancer pain management. Information addressed nine
major concerns contributing to reluctance to report pain
and use analgesics: fatalism, addiction, desire to be
good, fear of distracting physicians, disease progression,
tolerance, side effects, religious fatalism, and prn meds
Theoretical basis: NR
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Table 4 Continued
First author,
year, country
Intervention: format*, resources
provided to carers, follow-up Duration and intensity of intervention† Provider, recipients, site of delivery.
Detail of intervention content
theoretical basis
Ward, 2009,
USA
Single face-to-face interactive education
session working through first 6 steps of
7-step intervention
Follow-up: 2 telephone calls address 7th
step
Initial session 20–80 min, depending on
participant needs
Follow-up phone calls at 2 and 4 weeks after
initial session, lasting 5–10 min
Total duration 30–100 min
Intervention delivered by specially trained nurse or
psychologist at convenient location, usually the
patient’s home, to the patient alone or patient
and carer together
Follow-up phone calls: recipient (patient or
caregiver) NR
RIDcancerPAIN+ was designed to elicit and understand
patients’ representations of symptoms before providing
new information and developing strategies for behaviour
change in a 7-step process
1. Exploration of beliefs about cancer pain
2. Identification of misconceptions about pain and
analgesia use
3. Discussion of consequent limitations and losses
4. Tailored information provision, filling gaps, etc
5. Discussion of benefits of adopting new
information
6. Patient creates plan for changing how pain is
managed
7. Evaluation and revision of coping plans
(follow-up)
Theoretical basis: representational approach to patient
education
Capewell,
2010, UK
2 education sessions: 6 min video
shown, and printed information
provided, any questions answered
Copies of DVD and printed materials
Two sessions approximately 1 week apart.
Duration NR
Video (featuring palliative care clinicians) shown in
hospital outpatient clinic to patient alone or
patient and carer together by researcher who
answered questions
Brief structured educational intervention focusing on
cancer pain and the use of strong opioids, emphasising
that cancer pain can often be well controlled,
importance of pain assessment and good
communication. Addressed ‘common fears’ about
opioids found in previous research
Theoretical basis: NR
Vallerand,
2010, USA
Patients and carers
Initial visit (face-to-face) given printed
information; second visit face-to-face
education session. Extent of interaction
NR
Nurses providing home care
2 lecture/discussion sessions
Printed resources on pain management
and opioid-related side effects
Patients and carers
First contact duration NR. Education 1 week
later, duration 1 h
Nurses
1st teaching session 4 h
4–6 weeks to apply in practice
2nd teaching session duration NR
Patients and carers visited at home by PI or
researcher; education session delivered by PI to
patient alone or patient and carer together
Nurses’ teaching delivered in classroom, NR by
whom, and size of group
Power Over Pain: a structured educational intervention
on management of pain and side effects in patients
with cancer
For patients and carers: importance of pain
management; misconceptions; analgesics; side-effect
management. Based on program for nurses, ‘presented
at a level appropriate for the layman’
For nurses, 1st session: misconceptions about
analgesics; pharma pain control and side effects;
communicating with physicians and patients. 2nd
session: ‘more advanced concepts’, ie, dose titration
and managing side effects. Role play and assertiveness
training to develop communication advocacy skills
Theoretical basis: NR
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RIDcancerPAIN+ was based on the ‘representational
approach to patient education’ which emphasises dis-
covering an individual’s understanding of their illness
or treatment before providing information to address
any gaps or misconceptions.38 None of the interven-
tions was reported to have been informed by psycho-
social theory about the nature of the patient–carer
relationship or the caring role.
The majority of studies appear to have delivered the
same education to patients and family
carers.30 31 34 36 37 However, Keefe et al’s29 ‘partner-
guided pain management training’ explicitly posi-
tioned family carers in the role of coach ‘guiding and
encouraging the patient’ to use coping skills taught by
the nurse educator, who also gave carers feedback on
their performance as a coach. None of the studies
reported involving patients, family carers or health-
care professionals in the design or development of the
intervention.
Fidelity and quality of intervention delivery was
addressed to some degree in four studies. Those deli-
vering interventions used written manuals, booklets
or guides;29 30 37 completed checklists during educa-
tion sessions30 audio-taped sessions for later review
and/or rating;29 or their practice was observed during
training.33 Only one study reported a treatment fidel-
ity score (82%): all sessions were audio-taped, and
58% assessed against the intervention manual for
adherence.29
Impact of interventions
The studies specified a variety of family carer out-
comes, most selecting a combination of medicines-
specific or pain-specific and more global psychological
measures, and there was wide variation in how many
and when outcome measurements were recorded,
with one to six time points for follow-up, ranging
from immediately after the intervention to 6 months,
although most studies measured outcomes within
1 month. Further details of study design and out-
comes are provided in online supplementary appendix
1.2. Family carers’ knowledge and beliefs about pain
and medications were measured in seven studies,
using the knowledge subscale of the Family Pain
Questionnaire (FPQ)31 33–36 and/or the Barriers
Questionnaire (BQ).30 34 37 Five studies reported
improvements in family carers’ knowledge and beliefs:
four studies used the FPQ knowledge subscale31 33 35 36
and one study used the BQ.37 Three studies demon-
strated statistically significant treatment effects: two
using the FPQ35 36 and one using the BQ.37 Two of
these delivered lower intensity, minimally tailored
interventions,36 37 and the third a higher intensity,
more tailored intervention.35 Improved FPQ knowl-
edge scores were reported in two non-randomised
studies, but neither provided data.31 33 Two RCTs,
including Ward et al’s30 well-conducted study of a
lower intensity, tailored intervention, found no effectTa
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of interventions on FPQ knowledge subscale and/or
BQ scores.34
Three studies reported on the FPQ experience sub-
scale (six items which mainly assess family carer per-
ceptions of the patient’s pain and distress, with one
question about the carer’s perceived ability to control
the patient’s pain). Two studies found no statistically
significant change at 4 weeks;31 34 and one study
reported ‘improvements’ at 1 week, although no data
were provided.33
Family carers’ self-efficacy, or perceived control
over pain, was measured in two studies. Keefe
et al’s29 well-conducted RCTevaluated a higher inten-
sity, more tailored intervention, and found a statistic-
ally significant improvement in self-efficacy scores for
the treatment group, at a mean of 7 days (range 0–31)
postintervention. Vallerand et al’s34 cluster RCT of
two interventions (for nurses and patient–carer dyads)
found no effect of the dyad intervention on family
carers’ perceived control over pain, although family
carers whose nurses had received Power over Pain edu-
cation showed a statistically significant improvement
in perceived control over pain at 1 month compared
with controls. The intervention for patient–carer
dyads was lower intensity (extent of tailoring
unclear); nurse education involved two group teaching
sessions with a total duration of more than 4 h.
Adherence to medication was measured in two
studies: an RCT found a statistically significant effect
of the intervention on family carers’ self-reported
scores at 2 and 4 weeks;37 a small single-group pilot
study did not report carer data.31 Other, more global,
family carer outcomes were measured in three studies.
Keefe et al’s29 well-conducted RCT reported
improved Caregiver Strain Index scores for the inter-
vention group, a trend that did not reach statistical
significance. This study found no effect on family
carer mood,29 and another study reported measuring
carers’ quality of life but provided no data.33
Patient pain outcomes, measured using the Brief
Pain Inventory (BPI), were reported in six articles:
four studies found no statistically significant effect of
interventions on patients’ BPI scores,29 30 34 36 and
two reported statistically significant reductions in
pain.31 37 The remaining two articles33 35 did not
report patient outcomes from the study but cited pub-
lications that provided this information, which were
accessed: one study measured pain outcomes;39 and
the other assessed patient knowledge, but not pain.40
Ferrell et al39 found trends in mean and median
scores for pain intensity, pain distress and pain relief
recorded by patients in a ‘self-care log’ over the
5 weeks of the study, which indicated improvements
over time, although no statistical tests were applied.
None of the studies assessed adverse effects of inter-
ventions on family carers or patients, or discussed
possible harms. The review included exploratory and
feasibility studies, but there was little, if any,
discussion of acceptability of interventions to family
carers and patients, and not all authors accounted
fully for attrition rates. None of the studies included
qualitative data gathered from family carers.
DISCUSSION
Effects of interventions
The results indicate that educational interventions
with structured and tailored elements delivered in one
or more face-to-face sessions, supported by written
and/or other resources, and/or including further
contact for reinforcement and review, have the poten-
tial to improve carers’ knowledge and self-efficacy for
pain medicines management, and change misconcep-
tions about cancer pain and medications. Seven of the
eight studies included in the review evaluated family
carers’ knowledge about pain and medications: five
studies reported improvements, of which three
demonstrated statistically significant treatment effects,
although these studies were all categorised as poor
quality. Two RCTs found statistically significant
improvements in carers’ self-efficacy or perceived
control over pain. One was a well-conducted study
that also showed a positive effect on caregiver strain, a
trend that just failed to reach statistical significance.
None of the studies provided evidence to suggest that
pain management interventions had adverse effects or
could harm family carers or patients.
The studies provide equivocal evidence for the
impact of family carer interventions on patients’
experience of pain: four studies found no effect on
pain, and three studies reported positive effects.
Neither of the two well-conducted RCTs included in
the review found statistically significant treatment
effects on patient pain. In addition, no significant
changes in more global measures of family carer psy-
chological state were observed. Plausible explanations
can be put forward for non-significant outcomes, such
as assessment too soon after the intervention, and low
levels of pain in the patient sample so that floor
effects were encountered. Additionally, patient pain is
a distal indicator of the effect of an educational inter-
vention influenced by other factors, such as disease
progression, changes in treatment and psychosocial
variables, which make it difficult to attribute observed
effects (or lack of them) to the intervention. Authors
of other reviews of family carer interventions have
suggested that outcome measures should be chosen to
reflect the impacts that interventions can realistically
be expected to accomplish in a limited time.21
Quality of research studies
Only eight studies met the criteria for inclusion in the
review and all were conducted in developed countries,
the majority in the USA, limiting the ability to gener-
alise results to other health systems. Quality assess-
ment identified methodological limitations and
deficiencies in reporting, and comparability of results
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was compromised by heterogeneity of patient popula-
tions; diversity of interventions; use of different
outcome measures; and variation in when outcomes
were assessed. This suggests that we should be cau-
tious about interpreting findings and generalising
from this small collection of published reports, whose
results are at best equivocal.
The studies’ lack of assessment of potential adverse
intervention effects on family carers or patients is an
important omission in research on pain management in
palliative care because of the relationship between pain,
anxiety and coping, and the potential risk of negative
impacts if information content or timing of delivery is
misjudged. In addition, the studies reported only quanti-
tative outcomes: none, even those designated as feasibil-
ity studies, included qualitative methods to explore
intervention effects, positive or negative, on family
carers and patients, or to evaluate research processes.
This limits the usefulness of the studies for informing
future research and palliative care practice.
Our findings suggest that educational interventions
have the potential to help family carers manage
cancer pain and associated medications, but the
mechanisms that bring about positive effects remain
unclear. A theoretical framework was described for
only one intervention.30 and none was informed by
behaviour change theories. However, all the studies
appear to have been influenced by the literature on
‘barriers’ to the effective use of pain medication, and
most interventions incorporated elements to mitigate
culturally specific barriers, and/or elicit and address
individual beliefs known to inhibit effective use of
pain medicines. Implicit assumptions about how ‘bar-
riers’ can be overcome were stated by Cagle et al41 as:
‘increasing knowledge and improving attitudes about
pain management (the immediate effect of the inter-
vention) would lead to changes in behaviour such as
better administration and adherence to pain medica-
tions (a secondary effect), which will in turn lead to
improved pain relief for patients (the primary distal
effect)’. This proposed mechanism is helpful for speci-
fying appropriate outcome measures, but it does not
distinguish between patients, health professionals and
family carers. It does not take account of patient–
carer interdependency, the unique nature of the family
carer role, or the complex social and emotional
context of providing palliative care in the home. Lack
of theoretical underpinning for interventions includ-
ing family carers has been identified in a broader
review of cancer symptom management interven-
tions.23 Clarity about the theories or assumptions on
which interventions are based, and specification of
appropriate and sensitive outcome measures, could
greatly strengthen future studies.
Unpacking interventions: what works best?
The interventions included in the review have been
categorised broadly as educational, but comparisons
across studies proved difficult because of heterogen-
eity in intervention characteristics, such as format,
content, duration and method of delivery. Owing to
this diversity and the small number and limited
quality of the studies, we were unable to discern any
clear pattern of association between particular inter-
vention characteristics and measured effects on family
carer outcomes. There was no indication that
outcomes were improved by providing multiple
face-to-face education sessions, or by spending more
time with family carers. Reviews of cancer pain self-
management interventions have reported similar
findings,17 19 although Cummings et al18 described a
relationship between higher educational ‘dose’ patient
interventions and improved outcomes in pain manage-
ment knowledge, skills and attitudes, and pain
control. Another feature of educational interventions
that has been linked to efficacy is the ability to ‘tailor’
delivery to address individual gaps in knowledge,
needs and circumstances.18 We found interventions
varied in the emphasis placed on individualising infor-
mation and education, but there was no discernible
pattern in effects, a finding that is consistent with
Koller et al’s19 review of cancer pain self-management
interventions.
It is worth noting that intervention duration and tai-
loring are connected, since tailoring is likely to result
in education sessions of variable duration, as demon-
strated in the study by Ward et al.30 This raises ques-
tions about assessing ‘dose’ or ‘intensity’ based only
on time, or attempting to determine an optimal inter-
vention dose or duration. Bennett et al17 concluded
that duration may be less important than other aspects
of pain management interventions, yet to be eluci-
dated by research. However, we have doubts about
the value of trying to isolate discrete ‘active ingredi-
ents’ of complex interventions, whose properties are
better understood as emergent and contingent on con-
textual factors,42 which may contribute substantially
to effectiveness.43 44 Understanding the context in
which interventions are delivered, and the influence
of contextual factors on outcomes merit more atten-
tion in pain and medication management research.45
When is the best time to intervene?
A frequently asked question is ‘when might be the
most appropriate time, in relation to the course of the
patient’s illness, treatment or experience of pain, to
provide pain and medication information and educa-
tion for family carers?’ It is especially salient in
end-of-life cancer research since ‘there is a small
window of opportunity to recruit carers when they
move into the caregiving role but are not over-
whelmed by it’,45 and pain medicines may include
opioids, which have negative associations that influ-
ence family carers’ readiness to learn, thus calling into
question the feasibility of early intervention. Most of
the studies in this review did not consider timing of
Review
10 Latter S, et al. BMJ Supportive & Palliative Care 2016;0:1–13. doi:10.1136/bmjspcare-2015-000958
group.bmj.com on May 20, 2016 - Published by http://spcare.bmj.com/Downloaded from 
intervention delivery, although participating patients
were at various stages of illness and treatment. One
study focused specifically on patients near the end of
life: Keefe et al’s29 well-conducted RCT recruited
patients experiencing pain, and who were eligible for
US hospice care, that is, with <6 months life expect-
ancy, and demonstrated statistically significant effects
on family carer self-efficacy but not patients’ pain. A
recent US study by Cagle et al41 recruited a similar
population and found that a brief, tailored pain man-
agement intervention produced statistically significant
improvements in family carers’ knowledge, attitudes
and assessment of patient pain at 2 weeks. We suggest
that these positive effects may be due, in part, to deli-
vering an appropriate intervention to a well-defined
group for whom pain management is a pressing
concern. In addition, transition to hospice care in the
USA (and palliative care in the UK) is a significant
milestone for patients and family carers, when carers
may recognise the need to take on more responsibility
for managing pain medication, and so be receptive to
help. Targeting interventions at specific groups, pos-
sibly identified at a key point in the palliative care
pathway, in addition to individualising content in
response to individual needs, should be considered in
future studies.
Recruiting patients at a particular point of contact
with services is convenient for research purposes, but
clearly this will not achieve optimal timing of inter-
vention for all participants. Stajduhar et al46 described
wide variation in family carers’ preferences for when
and how they received or accessed information and
support, which indicates that a standardised approach
may be inappropriate. In Healy et al’s47 study of
introducing a subcutaneous medication management
intervention for family carers, palliative care nurses
rejected the idea of defining an objective, fixed ‘right
time’ based on the patient’s palliative care trajectory,
in favour of making the decision with each family
carer individually. We suggest that for pain and medi-
cation management interventions it is more meaning-
ful to ask not about timing, per se, but how to
provide timely help for family carers, conceptualising
‘timeliness’ as a subjective and context-dependent
aspect of an intervention.
Implications for research
This review confirms that further good-quality
research is needed to identify how best to help family
carers of patients with advanced cancer to manage
pain and pain medicines. Some authors have argued
that research with patients receiving palliative care,
and their family carers, would be strengthened by
taking a more pragmatic approach, in particular, by
evaluating interventions that are brief and easily deliv-
ered in the context of routine care.17 48 The studies
reviewed here offer little indication of what might be
achievable by healthcare professionals in routine
practice, although recently published studies by Healy
et al47 and Cagle et al41 describe interventions inte-
grated with regular nursing care. In Cagle et al’s41 US
study, hospice nurses delivered a brief, tailored pain
management intervention to newly registered patients
and their family carers, with positive effects reported
by carers.
None of the studies in the review reported follow-
ing recommended research practices by involving
family carers and healthcare professionals in develop-
ing intervention studies.49 Future research would be
strengthened by engaging family carers to ensure that
interventions meet their needs and preferences, and in
involving healthcare professionals to design interven-
tions that can be assimilated into clinical practice and
service delivery. In particular, participation by family
carers and clinicians could facilitate finding solutions
to the issue of timeliness discussed earlier, by identify-
ing timings and settings for intervention compatible
with local practice in when and how patients and
family carers are introduced to pain medicines. Our
review also indicates that more attention should be
given to the process of developing interventions
informed by theory that are likely to be effective in
pragmatic trials. We suggest that these recommenda-
tions for future research could be addressed by adopt-
ing a complex interventions framework for the
development and testing of future interventions for
family carers.50
We found an absence of qualitative research in the
studies reviewed, despite widespread acceptance of its
value in process evaluation, and as a complement to
quantifiable outcomes.44 Pragmatic studies of pain
medication management interventions would be
enhanced by using qualitative methods to illuminate
the influence of contextual factors on intervention
delivery and to investigate how clinicians, family carers
and patients experience pain management education,
including identifying adverse and unanticipated effects.
Implications for clinical practice
Research has established that patients benefit from
education about managing cancer pain,17 and it is
recognised that nurses have a central role in meeting
patients’ information needs and providing advice on
analgesia. However, family carers consistently identify
unmet needs for appropriate and timely information
and support to help them manage pain and medica-
tions, especially as patients approach the end of life.
Current evidence suggests that there is potential for
health professionals to improve family carers’ knowl-
edge and self-efficacy in managing cancer pain medi-
cines by including them with patients during
face-to-face education, supported by written or other
materials, and appropriate follow-up, an approach
that has not been linked with any obvious or serious
harms. Currently, there is insufficient evidence on
which to base more specific directions about
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interventions likely to be effective in clinical practice,
or how, where and when they should be delivered.
Strengths and limitations of the review
As far as we are aware, this is the most comprehensive
systematic review of pain medication management inter-
ventions for family carers of patients with advanced
cancer. The review has some limitations: articles pub-
lished in languages other than English were not included,
and restricting the study population to family carers of
patients with advanced cancer reduced the number of eli-
gible studies. While there are strong arguments for main-
taining a narrow focus, the review may have benefited
from a broader definition of the study population, for
example, including family carers of patients with cancer
at all stages, or patients with non-cancer diagnoses
experiencing pain near the end of life, which may have
yielded more studies, a wider range of interventions, and
allowed consideration of generalisability of results. The
review could also have been extended to include inter-
ventions to help family carers manage not only pain but
also other symptoms of advanced cancer and the medi-
cines associated with these symptoms.
CONCLUSIONS
There is scant good-quality research to inform answers
to the question of how family carers of patients who
have advanced cancer can be helped to manage pain
medicines. Evidence from the eight studies reviewed sug-
gests that educational interventions delivered
face-to-face, supported by written and/or other resources
and appropriate follow-up, have the potential to
improve family carers’ knowledge and self-efficacy for
pain management, and reduce attitudinal barriers. No
adverse effects of interventions were reported. There
were no discernible patterns of association between par-
ticular intervention characteristics, for example, time
spent in interaction or providing individualised informa-
tion, and effects on family carer outcomes. Future inter-
vention research would be strengthened by addressing
methodological issues and giving more attention to the
development of interventions that address family carers’
needs and concerns and are informed by theory, appro-
priately targeted, and compatible with local clinical prac-
tice and service delivery.
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